Genscript Biotech Valuation
| GNNSF Stock | USD 1.84 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Genscript Biotech retains a regular Real Value of $1.92 per share. The prevalent price of the firm is $1.84. Our model calculates the value of Genscript Biotech from evaluating the firm fundamentals such as Return On Equity of -0.56, current valuation of 5.11 B, and Return On Asset of -0.12 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Genscript Biotech's price fluctuation is very risky at this time. Calculation of the real value of Genscript Biotech is based on 3 months time horizon. Increasing Genscript Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Genscript pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Genscript Biotech. Since Genscript Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Genscript Pink Sheet. However, Genscript Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.84 | Real 1.92 | Hype 1.84 | Naive 1.83 |
The real value of Genscript Pink Sheet, also known as its intrinsic value, is the underlying worth of Genscript Biotech Company, which is reflected in its stock price. It is based on Genscript Biotech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Genscript Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Genscript Biotech helps investors to forecast how Genscript pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genscript Biotech more accurately as focusing exclusively on Genscript Biotech's fundamentals will not take into account other important factors: About Genscript Biotech Valuation
The pink sheet valuation mechanism determines Genscript Biotech's current worth on a weekly basis. Our valuation model uses a comparative analysis of Genscript Biotech. We calculate exposure to Genscript Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Genscript Biotech's related companies.Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the Peoples Republic of China, Japan, the other Asia Pacific regions, and internationally. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the Peoples Republic of China. Genscript Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5573 people.
8 Steps to conduct Genscript Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Genscript Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Genscript Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Genscript Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Genscript Biotech's revenue streams: Identify Genscript Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Genscript Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Genscript Biotech's growth potential: Evaluate Genscript Biotech's management, business model, and growth potential.
- Determine Genscript Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Genscript Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Genscript Biotech Growth Indicators
Investing in growth stocks can be very risky. If the company such as Genscript Biotech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.1 B | |
| Forward Price Earnings | 79.3651 | |
| Retained Earnings | -522.9 M |
Complementary Tools for Genscript Pink Sheet analysis
When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |